SPOTLIGHT -
Lilly's New Blood Thinner No Blockbuster
Safety Risks, Generic Threat Scale Down Big Hopes
Stormy Forecast for Pharma in 2008
Bright Spots Are Emerging Markets, Specialty Drugs, Says IMS Health